financetom
Business
financetom
/
Business
/
Archer Aviation Stock Tumbles After The Bell: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Archer Aviation Stock Tumbles After The Bell: What's Going On?
Nov 6, 2025 2:47 PM

Archer Aviation Inc ( ACHR ) reported third-quarter financial results after the market close on Thursday. Here’s what investors need to know.

ACHR is among today’s weakest performers. Check out the latest moves here.

Q3 Highlights: Archer Aviation ( ACHR ) reported a third-quarter loss of 20 cents per share, beating analyst estimates for a loss of 31 cents per share, according to Benzinga Pro.

The pre-revenue company announced a registered direct offering of 81.25 million shares at a price of $8 per share. The company anticipates net proceeds of $171 million, which will be used to fund a pending acquisition and planned redevelopment of Hawthorne Airport.

Archer announced that it signed definitive agreements to acquire Hawthorne Airport in Los Angeles for $126 million in cash. The company said the airport will serve as an operational hub for its planned LA air taxi network. It will also act as a test bed for the AI-powered aviation technologies Archer is developing and plans to deploy.

“The era of advanced aviation has arrived — not as a distant vision, but as a tangible reality. At Archer, we are not waiting for the future; we are building it. The time to seize this transformative opportunity is now,” said Adam Goldstein, CEO of Archer Aviation ( ACHR ).

Archer said it anticipates a fourth-quarter adjusted EBITDA loss of $110 million to $140 million. The company reported an adjusted EBITDA loss of $116.1 million in the third quarter.

Archer is currently discussing the aforementioned announcements on an earnings call that started at 5 p.m. ET.

ACHR Price Action: Archer shares were down 9.12% in after-hours, trading at $8.09 at the time of publication on Thursday, according to Benzinga Pro.

Read Next:

Opendoor Q3 Earnings: ‘We Are Refounding Opendoor As A Software And AI Company’

Image: Shutterstock.com

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved